CCIA
IDXX icon

Campbell & Co Investment Adviser’s Idexx Laboratories IDXX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.07M Sell
5,836
-1,936
-25% -$1.09M 0.16% 192
2026
Q1 		$4.37M Buy
7,772
+6,534
+528% +$4.19M 0.25% 95
2025
Q4 		$838K Buy
+1,238
New +$843K 0.04% 631
2025
Q3 		– Sell
-5,051
Closed -$2.71M – 1236
2025
Q2 		$2.71M Buy
+5,051
New +$2.42M 0.17% 166
2025
Q1 		– Sell
-2,939
Closed -$1.22M – 1161
2024
Q4 		$1.22M Sell
2,939
-5,898
-67% -$2.59M 0.09% 324
2024
Q3 		$4.46M Buy
+8,837
New +$4.29M 0.33% 43
2024
Q2 		– Sell
-8,647
Closed -$4.67M – 1173
2024
Q1 		$4.67M Buy
8,647
+6,109
+241% +$3.34M 0.4% 19
2023
Q4 		$1.41M Buy
2,538
+1,174
+86% +$551K 0.13% 242
2023
Q3 		$596K Sell
1,364
-679
-33% -$339K 0.07% 442
2023
Q2 		$1.03M Buy
2,043
+856
+72% +$410K 0.18% 143
2023
Q1 		$594K Buy
1,187
+477
+67% +$228K 0.11% 349
2022
Q4 		$290K Sell
710
-789
-53% -$306K 0.07% 565
2022
Q3 		$488K Buy
1,499
+588
+65% +$216K 0.11% 327
2022
Q2 		$320K Buy
911
+524
+135% +$214K 0.09% 432
2022
Q1 		$212K Sell
387
-521
-57% -$274K 0.06% 608
2021
Q4 		$598K Buy
908
+450
+98% +$282K 0.2% 147
2021
Q3 		$285K Sell
458
-950
-67% -$638K 0.09% 386
2021
Q2 		$889K Buy
+1,408
New +$777K 0.37% 61
2020
Q1 		– Sell
-1,638
Closed -$428K – 254
2019
Q4 		$428K Sell
1,638
-89
-5% -$23.5K 0.13% 284
2019
Q3 		$470K Buy
1,727
+706
+69% +$196K 0.18% 201
2019
Q2 		$281K Buy
1,021
+111
+12% +$27.3K 0.13% 326
2019
Q1 		$203K Sell
910
-754
-45% -$156K 0.1% 451
2018
Q4 		$343K Buy
1,664
+800
+93% +$164K 0.34% 110
2018
Q3 		$216K Buy
+864
New +$210K 0.15% 317
2017
Q3 		– Sell
-1,702
Closed -$275K – 404
2017
Q2 		$275K Buy
+1,702
New +$276K 0.26% 162

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Campbell & Co Investment Adviser's IDXX Position: Q2 2026 in Review

Campbell & Co Investment Adviser reduced its Idexx Laboratories (IDXX) stake by 25% in Q2 2026, selling an estimated $1.09M and leaving 5,836 shares worth $3.07M. The position accounts for 0.16% of the portfolio, ranked #192.

Campbell & Co Investment Adviser first reported a position in IDXX in Q2 2017 and has held it in 25 quarters since. The position peaked at $4.67M in Q1 2024. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Campbell & Co Investment Adviser held 5,836 shares of Idexx Laboratories worth $3.07M as of Q2 2026.
  • Campbell & Co Investment Adviser sold 1,936 Idexx Laboratories shares in Q2 2026, an estimated $1.09M.
  • Idexx Laboratories made up 0.16% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #192 holding.
  • Campbell & Co Investment Adviser first reported a position in Idexx Laboratories in Q2 2017 and has held it in 25 quarters since.
  • Campbell & Co Investment Adviser's Idexx Laboratories position peaked at $4.67M in Q1 2024.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.